Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms.

Jaramillo CAC, Belli S, Cascais AC, Dudal S, Edelmann MR, Haak M, Brun ME, Otteneder MB, Ullah M, Funk C, Schuler F, Simon S.

MAbs. 2017 Jul;9(5):781-791. doi: 10.1080/19420862.2017.1320008. Epub 2017 Apr 25.

2.

Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB.

Dudal S, Hinton H, Giusti AM, Bacac M, Muller M, Fauti T, Colombetti S, Heckel T, Giroud N, Klein C, Umaña P, Benincosa L, Bachl J, Singer T, Bray-French K.

J Immunother. 2016 Sep;39(7):279-89. doi: 10.1097/CJI.0000000000000132.

PMID:
27404941
3.

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.

Bacac M, Fauti T, Sam J, Colombetti S, Weinzierl T, Ouaret D, Bodmer W, Lehmann S, Hofer T, Hosse RJ, Moessner E, Ast O, Bruenker P, Grau-Richards S, Schaller T, Seidl A, Gerdes C, Perro M, Nicolini V, Steinhoff N, Dudal S, Neumann S, von Hirschheydt T, Jaeger C, Saro J, Karanikas V, Klein C, Umaña P.

Clin Cancer Res. 2016 Jul 1;22(13):3286-97. doi: 10.1158/1078-0432.CCR-15-1696. Epub 2016 Feb 9.

4.

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

Dudal S, Subramanian K, Flandre T, Law WS, Lowe PJ, Skerjanec A, Genin JC, Duval M, Piequet A, Cordier A, Jarai G, Van Heeke G, Taplin S, Krantz C, Jones S, Warren AP, Brennan FR, Sims J, Lloyd P.

MAbs. 2015;7(5):829-37. doi: 10.1080/19420862.2015.1060384.

5.

Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment.

Kelley M, Stevenson L, Golob M, Devanarayan V, Pedras-Vasconcelos J, Staack RF, Jenkins R, Booth B, Wakshull E, Bowsher R, Rock M, Dudal S, DeSilva B.

AAPS J. 2015 Jul;17(4):1019-24. doi: 10.1208/s12248-015-9767-z. Epub 2015 Apr 30.

6.

Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance.

Booth B, Arnold ME, DeSilva B, Amaravadi L, Dudal S, Fluhler E, Gorovits B, Haidar SH, Kadavil J, Lowes S, Nicholson R, Rock M, Skelly M, Stevenson L, Subramaniam S, Weiner R, Woolf E.

AAPS J. 2015 Mar;17(2):277-88. doi: 10.1208/s12248-014-9696-2. Epub 2014 Dec 31.

7.

Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibody.

Law WS, Genin JC, Miess C, Treton G, Warren AP, Lloyd P, Dudal S, Krantz C.

Bioanalysis. 2014;6(23):3225-35. doi: 10.4155/bio.14.167.

PMID:
25529889
8.

How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics - a reflection of the European Bioanalysis Forum.

Dudal S, Staack RF, Stoellner D, Fjording MS, Vieser E, Pascual MH, Brudny-Kloeppel M, Golob M.

Bioanalysis. 2014 May;6(10):1339-48. doi: 10.4155/bio.14.90.

PMID:
24958118
9.

Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Dudal S, Baltrukonis D, Crisino R, Goyal MJ, Joyce A, Osterlund K, Smeraglia J, Taniguchi Y, Yang J.

AAPS J. 2014 Mar;16(2):194-205. doi: 10.1208/s12248-013-9552-9. Epub 2013 Dec 17. Review.

10.

2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS.

Stevenson L, Garofolo F, DeSilva B, Dumont I, Martinez S, Rocci M, Amaravadi L, Brudny-Kloeppel M, Musuku A, Booth B, Dicaire C, Wright L, Mayrand-Provencher L, Losauro M, Gouty D, Arnold M, Bansal S, Dudal S, Dufield D, Duggan J, Evans C, Fluhler E, Fraser S, Gorovits B, Haidar S, Hayes R, Ho S, Houghton R, Islam R, Jenkins R, Katori N, Kaur S, Kelley M, Knutsson M, Lee J, Liu H, Lowes S, Ma M, Mikulskis A, Myler H, Nicholson B, Olah T, Ormsby E, Patel S, Pucci V, Ray C, Schultz G, Shih J, Shoup R, Simon C, Song A, Neto JT, Theobald V, Thway T, Wakelin-Smith J, Wang J, Wang L, Welink J, Whale E, Woolf E, Xu R.

Bioanalysis. 2013 Dec;5(23):2903-18. doi: 10.4155/bio.13.238. Epub 2013 Oct 10.

11.

2012 white paper on recent issues in bioanalysis and alignment of multiple guidelines.

DeSilva B, Garofolo F, Rocci M, Martinez S, Dumont I, Landry F, Dicaire C, Szekely-Klepser G, Weiner R, Arnold M, Bansal S, Bateman K, Bauer R, Booth B, Davis S, Dudal S, Gouty D, Grundy J, Haidar S, Hayes R, Jemal M, Kaur S, Kelley M, Knutsson M, Le Blaye O, Lee J, Lowes S, Ma M, Mitsuoka T, Neto JT, Nicholson R, Ormsby E, Sailstad J, Stevenson L, Tang D, Welink J, Viswanathan CT, Wang L, Woolf E, Yang E.

Bioanalysis. 2012 Sep;4(18):2213-26. doi: 10.4155/bio.12.205.

12.

Human CD4+ invariant NKT cells are involved in antibacterial immunity against Brucella suis through CD1d-dependent but CD4-independent mechanisms.

Bessoles S, Dudal S, Besra GS, Sanchez F, Lafont V.

Eur J Immunol. 2009 Apr;39(4):1025-35. doi: 10.1002/eji.200838929.

13.

IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.

Bessoles S, Fouret F, Dudal S, Besra GS, Sanchez F, Lafont V.

J Leukoc Biol. 2008 Jul;84(1):224-33. doi: 10.1189/jlb.1007669. Epub 2008 May 2.

PMID:
18456817
14.

Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis.

Dudal S, Turriere C, Bessoles S, Fontes P, Sanchez F, Liautard J, Liautard JP, Lafont V.

J Immunol. 2006 Oct 15;177(8):5533-9.

15.

Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice.

Sebastiani G, Krzywkowski P, Dudal S, Yu M, Paquette J, Malo D, Gervais F, Tremblay P.

Hum Mol Genet. 2006 Aug 1;15(15):2313-23. Epub 2006 Jun 19.

PMID:
16785251
16.

Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation.

Jimenez de Bagues MP, Dudal S, Dornand J, Gross A.

Clin Immunol. 2005 Mar;114(3):227-38. Review. Erratum in: Clin Immunol. 2005 Sep;116(3):305. Maria-Pilar, Jimenez de Bagues [corrected to Jimenez de Bagues, Maria-Pilar].

PMID:
15721833
17.

Vgamma9Vdelta2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella.

Oliaro J, Dudal S, Liautard J, Andrault JB, Liautard JP, Lafont V.

J Leukoc Biol. 2005 May;77(5):652-60. Epub 2005 Jan 24.

PMID:
15668339
18.

Differences in the amyloid-beta-induced inflammatory response in microglia from C57BL/6 and A/J strains of mice.

Dudal S, Morissette C, Lacombe D, Tremblay P, Gervais F.

J Neuroimmunol. 2004 Aug;153(1-2):26-35.

PMID:
15265660
19.

Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.

Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F.

Neurobiol Aging. 2004 Aug;25(7):861-71.

PMID:
15212840
20.

Specific signaling pathways triggered by IL-2 in human V gamma 9V delta 2 T cells: an amalgamation of NK and alpha beta T cell signaling.

Lafont V, Loisel S, Liautard J, Dudal S, Sablé-Teychené M, Liautard JP, Favero J.

J Immunol. 2003 Nov 15;171(10):5225-32.

Supplemental Content

Support Center